Literature DB >> 17674045

No association between MDR1 (ABCB1) 2677G>T and 3435C>T polymorphism and sporadic colorectal cancer among Bulgarian patients.

Darinka Todorova Petrova1, Petya Nedeva, Svilen Maslyankov, Svetoslav Toshev, Nikolay Yaramov, Srebrena Atanasova, Draga Toncheva, Michael Oellerich, Nicolas von Ahsen.   

Abstract

PURPOSE: Variation in genetic factors together with xenobiotic exposure may result in increased risk of colorectal cancer. The P-glycoprotein (P-gp) is highly expressed in the apical membrane of enterocytes, where it pumps xenobiotics from the enterocytes back into the intestinal lumen. Thus, polymorphisms that reduce the activity of the MDR1 (ABCB1) efflux pump are potential risk factors for colorectal carcinogenesis. The aim of the present study is to genotype the MDR1 2677G>T (rs2032582) and 3435C>T (rs1045642) polymorphism in patients with colorectal cancer and controls and to identify a possible association between individual genetic variation and susceptibility to colorectal cancer.
METHODS: In the present study, 146 Bulgarian patients with sporadic colorectal cancer and 160 healthy Bulgarian volunteers were evaluated for the two polymorphisms in MDR1. Polymorphisms were identified using rapid-cycle real-time amplification with allele-specific probes and subsequent melting curve analyses on a LightCyclertrade mark (Roche Diagnostics, Mannheim, Germany).
RESULTS: No differences were found between the frequencies of the two mutant alleles in the tumor tissue from the cases and lymphocytes from the controls [frequencies of 2677T: 43.5% in patients and 44.1% in controls; frequencies of 3435T: 48.3% in patients and 50.9% in controls (both P > 0.05)]. The MDR1 polymorphic sequence of the tumor tissue always matched that of normal intestinal tissue from the same patient. Consequently, genotyping of DNA from archived tumor tissues is a valid alternative to the use of leukocyte DNA.
CONCLUSIONS: The present study suggests that MDR1 2677G>T and 3435C>T polymorphism is not a risk factor for sporadic colon cancer among Bulgarians and that somatic mutation at these sites is not involved in the genesis of colon tumors. Further examination using larger number of samples must be necessary to reach to more reliable conclusions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17674045     DOI: 10.1007/s00432-007-0279-9

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  42 in total

Review 1.  Biochemical, cellular, and pharmacological aspects of the multidrug transporter.

Authors:  S V Ambudkar; S Dey; C A Hrycyna; M Ramachandra; I Pastan; M M Gottesman
Journal:  Annu Rev Pharmacol Toxicol       Date:  1999       Impact factor: 13.820

2.  Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption.

Authors:  Carmen Lilla; Emaculate Verla-Tebit; Angela Risch; Birgit Jäger; Michael Hoffmeister; Hermann Brenner; Jenny Chang-Claude
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-01       Impact factor: 4.254

3.  ABCB1/MDR1 gene determines susceptibility and phenotype in ulcerative colitis: discrimination of critical variants using a gene-wide haplotype tagging approach.

Authors:  G-T Ho; N Soranzo; E R Nimmo; A Tenesa; D B Goldstein; J Satsangi
Journal:  Hum Mol Genet       Date:  2006-01-24       Impact factor: 6.150

Review 4.  Colorectal cancer prevention: is an ounce of prevention worth a pound of cure?

Authors:  Sharlene Gill; Frank A Sinicrope
Journal:  Semin Oncol       Date:  2005-02       Impact factor: 4.929

5.  No influence of the MDR-1 C3435T polymorphism or a CYP3A4 promoter polymorphism (CYP3A4-V allele) on dose-adjusted cyclosporin A trough concentrations or rejection incidence in stable renal transplant recipients.

Authors:  N von Ahsen; M Richter; C Grupp; B Ringe; M Oellerich; V W Armstrong
Journal:  Clin Chem       Date:  2001-06       Impact factor: 8.327

Review 6.  The staging of colorectal cancer: 2004 and beyond.

Authors:  Carolyn C Compton; Frederick L Greene
Journal:  CA Cancer J Clin       Date:  2004 Nov-Dec       Impact factor: 508.702

7.  The role of P-glycoprotein (MDR1) polymorphisms and mutations in colorectal cancer.

Authors:  U Potocnik; M R Glavac; R Golouh; D Glavac
Journal:  Pflugers Arch       Date:  2001       Impact factor: 3.657

Review 8.  Genetic predisposition to colorectal cancer.

Authors:  Albert de la Chapelle
Journal:  Nat Rev Cancer       Date:  2004-10       Impact factor: 60.716

9.  MDR1 single nucleotide polymorphism C3435T in normal colorectal tissue and colorectal carcinomas detected by MALDI-TOF mass spectrometry.

Authors:  A Humeny; F Rödel; C Rödel; R Sauer; L Füzesi; C Becker; T Efferth
Journal:  Anticancer Res       Date:  2003 May-Jun       Impact factor: 2.480

Review 10.  Transporter-enzyme interactions: implications for predicting drug-drug interactions from in vitro data.

Authors:  L Z Benet; C L Cummins; C Y Wu
Journal:  Curr Drug Metab       Date:  2003-10       Impact factor: 3.731

View more
  14 in total

1.  Inter and intra-ethnic differences in the distribution of the molecular variants of TPMT, UGT1A1 and MDR1 genes in the South Indian population.

Authors:  Gurusamy Umamaheswaran; Dhakchinamoorthi Krishna Kumar; Dhandapani Kayathiri; Subramanian Rajan; Deepak Gopal Shewade; Steven Aibor Dkhar; Sajjanavar Manjunath; Prayaga Ushakiran; Gangadharan Reneega; Kukreti Ritushree; Chandrasekaran Adithan
Journal:  Mol Biol Rep       Date:  2012-02-09       Impact factor: 2.316

2.  MDR1 C3435T polymorphism and cancer risk: a meta-analysis based on 39 case-control studies.

Authors:  Xiaojing Sheng; Limei Zhang; Na Tong; Dewei Luo; Meilin Wang; Min Xu; Zhengdong Zhang
Journal:  Mol Biol Rep       Date:  2012-02-04       Impact factor: 2.316

3.  MDR1 gene C3435T polymorphism and cancer risk: a meta-analysis of 34 case-control studies.

Authors:  Jun Wang; Baocheng Wang; Jingwang Bi; Kainan Li; Jianshi Di
Journal:  J Cancer Res Clin Oncol       Date:  2012-02-23       Impact factor: 4.553

4.  Association between the C3435T polymorphism of ABCB1/MDR1 gene (rs1045642) and colorectal cancer susceptibility : a meta-analysis based on 11,339 subjects.

Authors:  Li Zhao; Kai Li; Wusheng Li; Zhen Yang
Journal:  Tumour Biol       Date:  2013-03-16

5.  ABCB1 gene polymorphisms and haplotype analysis in colorectal cancer.

Authors:  Mariusz Panczyk; Ewa Balcerczak; Sylwester Piaskowski; Krzysztof Jamroziak; Grazyna Pasz-Walczak; Marek Mirowski
Journal:  Int J Colorectal Dis       Date:  2009-05-05       Impact factor: 2.571

6.  A comprehensive investigation on common polymorphisms in the MDR1/ABCB1 transporter gene and susceptibility to colorectal cancer.

Authors:  Daniele Campa; Juan Sainz; Barbara Pardini; Ludmila Vodickova; Alessio Naccarati; Anja Rudolph; Jan Novotny; Asta Försti; Stephan Buch; Witigo von Schönfels; Clemens Schafmayer; Henry Völzke; Michael Hoffmeister; Bernd Frank; Roberto Barale; Kari Hemminki; Jochen Hampe; Jenny Chang-Claude; Hermann Brenner; Pavel Vodicka; Federico Canzian
Journal:  PLoS One       Date:  2012-03-02       Impact factor: 3.240

7.  Colorectal cancer susceptibility: apparent gender-related modulation by ABCB1 gene polymorphisms.

Authors:  Marcella Martinelli; Luca Scapoli; Francesca Cura; Maria Teresa Rodia; Giampaolo Ugolini; Isacco Montroni; Rossella Solmi
Journal:  J Biomed Sci       Date:  2014-09-04       Impact factor: 8.410

Review 8.  Meta-Analysis of ABCB1 3435C>T Polymorphism and Colorectal Cancer.

Authors:  Dan Zhang; Cun Wang; Zongguang Zhou
Journal:  Pak J Med Sci       Date:  2013-09       Impact factor: 1.088

9.  The association between polymorphisms in the MDR1 gene and risk of cancer: a systematic review and pooled analysis of 52 case-control studies.

Authors:  Ling-Hui Wang; Yan-Bin Song; Wen-Ling Zheng; Ling Jiang; Wen-Li Ma
Journal:  Cancer Cell Int       Date:  2013-05-20       Impact factor: 5.722

10.  The importance of G2677T/A and C3435T polymorphisms of the MDR1 gene in the aetiology of colorectal cancer.

Authors:  Grzegorz Stańko; Marek Kamiński; Anna Bogacz; Agnieszka Seremak-Mrozikiewicz; Bogusław Kosiński; Joanna Bartkowiak-Wieczorek; Daniel Kotrych; Bogusław Czerny
Journal:  Prz Gastroenterol       Date:  2015-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.